Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Grants

Funding Acknowledgements

Disclosures: Michael Berk has received Grant/Research Support from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Australian Rotary Health Research Fund, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Servier. Flavio Kapczinski is supported by INCT-TM, CNPq, CAPES, SMRI and NARSAD. Is a consultant for, or receives research grants from Janssen, Lilly, Astra Zeneca, Abbott and Servier. Ana Cristina Andreazza has been supported by the Michael Smith Health Research Foundation and CAPES. Olivia Dean has received Grant/Research Support from Stanley Medical Research Foundation, Marian and E.H. Flack Trust, the Australia Rotary Health Research Fund and NHMRC. Clarissa Severino Gama has received unrestricted research grants from CNPq-Universal (477974/2009-0), CNPq-INCT-TM, CAPES and FIPE-HCPA. She has been a paid speaker for Lundbeck and Astra Zeneca and a consultant for Actelion Pharmaceuticals Ltd. She has received travel awards from Lilly and Janssen. Seetal Dodd has received Grant/Research Support from Stanley Medical Research Foundation, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Australian Rotary Health Research Fund, Bristol Myers Squibb, Eli Lilly, Organon, Novartis, Mayne Pharma and Servier, has been a speaker for Eli Lilly. Brian Dean has received Grant/Research Support from the NHMRC, NIH, Stanley Medical Research Foundation, NARSAD, Eli Lilly and the Rebecca L Cooper Medical Research Foundation; has been a speaker for Eli Lilly and Janssen Cilag and has acted as a Consultant for Merck and Bristol Myer Squibb. Pedro Magalhaes is supported by a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. Gin Malhi has served on a number of international and national pharmaceutical advisory boards, received funding for research and has been in receipt of honoraria for talks at sponsored meetings worldwide involving the following companies: Astra Zeneca, Eli Lilly, Janssen-Cilag, Lundbeck, Organon, Pfizer, Ranbaxy, Servier and Wyeth.